ELENA BURPEE: Open Payments
NPI 1356682306 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 11 payments from 5 companies in 2025. Trend: 2023 $1,943 · 2024 $631 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $130 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| Alkermes, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $31 |
Products named: INGREZZA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, ARISTADA, UZEDY.
Industry payments across CA — which companies pay providers there.
